Business
Novo Nordisk Stock Drops After Missed Target
Novo Nordisk's stock price fell after the company missed its Wegovy pill sales target. However, it also announced a positive outlook for the year.
Coverage timeline — 1 article
MarketWatch
The Danish drugmaker also revealed an improved outlook for the year.
2026-08-04 20:01 UTC